NEW YORK, April 16, 2015 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM) congratulates Corbus Pharmaceuticals Holdings, Inc., a clinical stage biopharmaceutical company, on its uplisting to the NASDAQ Capital Market. Corbus previously traded on OTCQB®, America's venture market for entrepreneurial and development stage companies.
Corbus began trading on the OTCQB Venture Marketplace on October 24, 2014, at $3 per share. Since that time, the company's share price has increased more than 13% to $3.40 per share and it has had a 30-day average daily dollar volume of $38,791. The company has a current market capitalization of $82.5 million.
"We applaud Corbus Pharmaceuticals on the achievement of this important milestone and are proud to have contributed to its growth as a public company," said R. Cromwell Coulson, President and CEO of OTC Markets Group. "Our OTCQX Best Marketplace and OTCQB Venture Marketplace provide a springboard for companies that are looking to grow their businesses and season for a U.S. exchange listing. We look forward to nurturing more companies like Corbus and wish the company and its management team continued success in the public markets."
In 2014, 83 companies graduated from the OTCQX®, OTCQB® and OTC Pink® marketplaces to the New York Stock Exchange, NYSE MKT or NASDAQ.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into marketplaces to inform investors of opportunities and risks: the OTCQX® Best Marketplace; the OTCQB® Venture Marketplace; and the OTC Pink® Open Marketplace. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, [email protected]
SOURCE OTC Markets Group Inc.